Digital therapeutics deals reached a peak in funding in 2018 with over $800M raised.
The average deal size for digital therapeutics saw a big jump from
$9M in 2014 to $18M in 2018.
Early-stage (seed/angel, Series A) deals have dominated digital therapeutics since 2014, making up more than 60% of the deals. However, 2018 saw a shift here as early-stage deals dropped to 45% while mid-stage deals (Series B, C) ticked up to 40%, showing signs of the market maturing.
Between 2009 and 2018 there were 2,500+ health data breaches of 500+ records each.
In a recent Ponemon Institute study, 67% of surveyed medical device manufacturers indicated that an attack on one or more of their medical devices is likely.
Cybersecurity startups offering products and services for the healthcare industry raised $3B across more than 85 deals since 2017. Notably, 2018 saw more deals and dollars go to these companies than any other year on record.